Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems

KA Berg, WP Clarke, C Sailstad, A Saltzman and S Maayani

Department of Anesthesiology, Mount Sinai School of Medicine, City University of New York, New York 10029.

The cDNAs for human 5-hydroxytryptamine (5-HT)2C and 5-HT2A receptors were stably transfected separately into parent Chinese hamster ovary cells, and cell lines in which levels of transfected receptor protein expression and accumulation of inositol phosphates in response to 5-HT were comparable were chosen for study. The effect of activation of these receptors on 5-HT1B-like receptor-mediated responsiveness (i.e., inhibition of forskolin-stimulated cAMP accumulation) was studied. Activation of 5-HT2C receptors with 5-HT (0.1-100 microM) abolished the 5-HT1B-like response, which returned when 5-HT2C receptors were blocked with mesulergine (1 microM). Furthermore, the maximal response to 5- carboxytryptamine was reduced in a concentration-dependent manner by the 5-HT2A/5-HT2C-selective partial agonist (+/-)-1-(2,5-dimethoxy-4- iodophenyl)-2-aminopropane. In contrast, activation of 5-HT2A receptors with either 5-HT or (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane did not alter the 5-HT1B-like response. The reduction of 5-HT1B-like responsiveness produced by 5-HT2C receptor activation was independent of protein kinase C activation and increases in the intracellular calcium concentration. Although 5-HT2A and 5-HT2C receptors are strikingly similar in structure and pharmacology, and the signal transduction systems coupled to these receptors have been thought to be similar, if not identical, these data provide the first evidence for fundamental differences in the signal transduction systems of these 5- HT2 receptor subtypes.

Volume 46, Issue 3, pp. 477-484, 09/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Y. Dai, N. L. Dudek, T. B. Patel, and N. A. Muma Transglutaminase-Catalyzed Transamidation: A Novel Mechanism for Rac1 Activation by 5-Hydroxytryptamine2A Receptor Stimulation J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 153 - 162. [Abstract] [Full Text] [PDF]

				K. D. G. Pfleger, A. J. Pawson, and R. P. Millar Changes to Gonadotropin-Releasing Hormone (GnRH) Receptor Extracellular Loops Differentially Affect GnRH Analog Binding and Activation: Evidence for Distinct Ligand-Stabilized Receptor Conformations Endocrinology, June 1, 2008; 149(6): 3118 - 3129. [Abstract] [Full Text] [PDF]

				A. J. Pawson, E. Faccenda, S. Maudsley, Z.-L. Lu, Z. Naor, and R. P. Millar Mammalian Type I Gonadotropin-Releasing Hormone Receptors Undergo Slow, Constitutive, Agonist-Independent Internalization Endocrinology, March 1, 2008; 149(3): 1415 - 1422. [Abstract] [Full Text] [PDF]

				R. K. Singh, J. Shi, B. W. Zemaitaitis, and N. A. Muma Olanzapine Increases RGS7 Protein Expression via Stimulation of the Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling Cascade J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 133 - 140. [Abstract] [Full Text] [PDF]

				K. A. Berg, S. Navailles, T. A. Sanchez, Y. M. Silva, M. D. Wood, U. Spampinato, and W. P. Clarke J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 260 - 268. [Abstract] [Full Text] [PDF]

				J- M Nothias, T. Mitsui, J. S. Shumsky, I. Fischer, M. D. Antonacci, and M. Murray Combined Effects of Neurotrophin Secreting Transplants, Exercise, and Serotonergic Drug Challenge Improve Function in Spinal Rats Neurorehabil Neural Repair, December 1, 2005; 19(4): 296 - 312. [Abstract] [PDF]

				A. M. Patwardhan, K. A. Berg, A. N. Akopain, N. A. Jeske, N. Gamper, W. P. Clarke, and K. M. Hargreaves Bradykinin-Induced Functional Competence and Trafficking of the {delta}-Opioid Receptor in Trigeminal Nociceptors J. Neurosci., September 28, 2005; 25(39): 8825 - 8832. [Abstract] [Full Text] [PDF]

				K. J. Sales, T. List, S. C. Boddy, A. R.W. Williams, R. A. Anderson, Z. Naor, and H. N. Jabbour A Novel Angiogenic Role for Prostaglandin F2{alpha}-FP Receptor Interaction in Human Endometrial Adenocarcinomas Cancer Res., September 1, 2005; 65(17): 7707 - 7716. [Abstract] [Full Text] [PDF]

				Y.-J. Huang, Y. Maruyama, K.-S. Lu, E. Pereira, I. Plonsky, J. E. Baur, D. Wu, and S. D. Roper Mouse Taste Buds Use Serotonin as a Neurotransmitter J. Neurosci., January 26, 2005; 25(4): 843 - 847. [Abstract] [Full Text] [PDF]

				Y.-J. Huang, Y. Maruyama, K.-S. Lu, E. Pereira, and S. D. Roper Mouse Taste Buds Release Serotonin in Response to Taste Stimuli Chem Senses, January 1, 2005; 30(suppl_1): i39 - i40. [Full Text] [PDF]

				C. Becamel, S. Gavarini, B. Chanrion, G. Alonso, N. Galeotti, A. Dumuis, J. Bockaert, and P. Marin The Serotonin 5-HT2A and 5-HT2C Receptors Interact with Specific Sets of PDZ Proteins J. Biol. Chem., May 7, 2004; 279(19): 20257 - 20266. [Abstract] [Full Text] [PDF]

				K. J. Sales, S. A. Milne, A. R. W. Williams, R. A. Anderson, and H. N. Jabbour Expression, Localization, and Signaling of Prostaglandin F2{alpha} Receptor in Human Endometrial Adenocarcinoma: Regulation of Proliferation by Activation of the Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling Pathways J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 986 - 993. [Abstract] [Full Text] [PDF]

				L. Davidson, A. J. Pawson, R. P. Millar, and S. Maudsley Cytoskeletal Reorganization Dependence of Signaling by the Gonadotropin-releasing Hormone Receptor J. Biol. Chem., January 16, 2004; 279(3): 1980 - 1993. [Abstract] [Full Text] [PDF]

				A. J. Pawson, S. R. Maudsley, J. Lopes, A. A. Katz, Y.-M. Sun, J. S. Davidson, and R. P. Millar Multiple Determinants for Rapid Agonist-Induced Internalization of a Nonmammalian Gonadotropin-Releasing Hormone Receptor: A Putative Palmitoylation Site and Threonine Doublet within the Carboxyl-Terminal Tail Are Critical Endocrinology, September 1, 2003; 144(9): 3860 - 3871. [Abstract] [Full Text] [PDF]

				S. A. Milne and H. N. Jabbour Prostaglandin (PG) F2{alpha} Receptor Expression and Signaling in Human Endometrium: Role of PGF2{alpha} in Epithelial Cell Proliferation J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1825 - 1832. [Abstract] [Full Text] [PDF]

				K. A. Berg, K. L. J. Evans, J. D. Cropper, and W. P. Clarke Temporal Regulation of Agonist Efficacy at 5-Hydroxytryptamine (5-HT)1A and 5-HT1B Receptors J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 200 - 205. [Abstract] [Full Text] [PDF]

				B. D. Stout, W. P. Clarke, and K. A. Berg Rapid Desensitization of the Serotonin2C Receptor System: Effector Pathway and Agonist Dependence J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 957 - 962. [Abstract] [Full Text] [PDF]

				N. R. S. Hanley and J. G. Hensler Mechanisms of Ligand-Induced Desensitization of the 5-Hydroxytryptamine2A Receptor J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 468 - 477. [Abstract] [Full Text] [PDF]

				K. J. Sales, A. A. Katz, B. Howard, R. P. Soeters, R. P. Millar, and H. N. Jabbour Cyclooxygenase-1 Is Up-Regulated in Cervical Carcinomas: Autocrine/Paracrine Regulation of Cyclooxygenase-2, Prostaglandin E Receptors, and Angiogenic Factors by Cyclooxygenase-1 Cancer Res., January 1, 2002; 62(2): 424 - 432. [Abstract] [Full Text] [PDF]

				K. A. Berg, B. D. Stout, S. Maayani, and W. P. Clarke Differences in Rapid Desensitization of 5-Hydroxytryptamine2A and 5-Hydroxytryptamine2C Receptor-Mediated Phospholipase C Activation J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 593 - 602. [Abstract] [Full Text] [PDF]

				J. F. Lopez-Gimenez, M. Villazon, J. Brea, M. I. Loza, J. M. Palacios, G. Mengod, and M. T. Vilaro Multiple Conformations of Native and Recombinant Human 5-Hydroxytryptamine2A Receptors Are Labeled by Agonists and Discriminated by Antagonists Mol. Pharmacol., October 1, 2001; 60(4): 690 - 699. [Abstract] [Full Text] [PDF]

				K. L. J. Evans, J. D. Cropper, K. A. Berg, and W. P. Clarke Mechanisms of Regulation of Agonist Efficacy at the 5-HT1A Receptor by Phospholipid-Derived Signaling Components J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1025 - 1035. [Abstract] [Full Text]

				C. B. Brink, S. M. Wade, and R. R. Neubig Agonist-Directed Trafficking of Porcine alpha 2A-Adrenergic Receptor Signaling in Chinese Hamster Ovary Cells: l-Isoproterenol Selectively Activates Gs J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 539 - 547. [Abstract] [Full Text]

				M. Sallese, S. Mariggiò, E. D'Urbano, L. Iacovelli, and A. De Blasi Selective Regulation of Gq Signaling by G Protein-Coupled Receptor Kinase 2: Direct Interaction of Kinase N Terminus with Activated Galpha q Mol. Pharmacol., April 1, 2000; 57(4): 826 - 831. [Abstract] [Full Text]

				C. A. Flanagan, W. Zhou, L. Chi, T. Yuen, V. Rodic, D. Robertson, M. Johnson, P. Holland, R. P. Millar, H. Weinstein, et al. The Functional Microdomain in Transmembrane Helices 2 and 7 Regulates Expression, Activation, and Coupling Pathways of the Gonadotropin-releasing Hormone Receptor J. Biol. Chem., October 8, 1999; 274(41): 28880 - 28886. [Abstract] [Full Text] [PDF]

				D. Kim, V. Adipudi, M. Shibayama, S. Giszter, A. Tessler, M. Murray, and K. J. Simansky Direct Agonists for Serotonin Receptors Enhance Locomotor Function in Rats that Received Neural Transplants after Neonatal Spinal Transection J. Neurosci., July 15, 1999; 19(14): 6213 - 6224. [Abstract] [Full Text] [PDF]

				K. A. Berg, B. D. Stout, J. D. Cropper, S. Maayani, and W. P. Clarke Novel Actions of Inverse Agonists on 5-HT2C Receptor Systems Mol. Pharmacol., May 1, 1999; 55(5): 863 - 872. [Abstract] [Full Text]

				C. Tournois, V. Mutel, P. Manivet, J.-M. Launay, and O. Kellermann Cross-talk between 5-Hydroxytryptamine Receptors in a Serotonergic Cell Line. INVOLVEMENT OF ARACHIDONIC ACID METABOLISM J. Biol. Chem., July 10, 1998; 273(28): 17498 - 17503. [Abstract] [Full Text] [PDF]

				K. A. Berg, S. Maayani, J. Goldfarb, C. Scaramellini, P. Leff, and W. P. Clarke Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus Mol. Pharmacol., July 1, 1998; 54(1): 94 - 104. [Abstract] [Full Text]